1-7 of 7
Mitsuhiko Noda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detailed Time Course of Decline in Serum C-Peptide Levels in Anti–Programmed Cell Death-1 Therapy–Induced Fulminant Type 1 Diabetes

Free
Daigo Saito, Yoichi Oikawa, Yuya Yano, Yuichi Ikegami, Atsushi Satomura, Masashi Isshiki, Susumu Kurihara, Ikuo Inoue, Mitsuhiko Noda, Akira Shimada
Journal: Diabetes Care
Diabetes Care 2019;42(3):e40–e41
https://doi.org/10.2337/dc18-1673
Published: 18 January 2019
View articletitled, Detailed Time Course of Decline in Serum C-Peptide Levels in Anti–Programmed Cell Death-1 Therapy–Induced Fulminant Type 1 Diabetes
Open the PDF for Detailed Time Course of Decline in Serum C-Peptide Levels in Anti–Programmed Cell Death-1 Therapy–Induced Fulminant Type 1 Diabetes in another window
Journal Articles

Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial

Free
Daisuke Ito, Satoshi Shimizu, Kazuyuki Inoue, Daigo Saito, Morifumi Yanagisawa, Kouichi Inukai, Yuji Akiyama, Yoshihiro Morimoto, Mitsuhiko Noda, Akira Shimada
Journal: Diabetes Care
Diabetes Care 2017;40(10):1364–1372
https://doi.org/10.2337/dc17-0518
Published: 27 July 2017
View articletitled, Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial
Open the PDF for Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Intensive Glycemic Therapy in Patients With Type 2 Diabetes on β-Blockers

Free
Tetsuro Tsujimoto, Takehiro Sugiyama, Mitsuhiko Noda, Hiroshi Kajio
Journal: Diabetes Care
Diabetes Care 2016;39(10):1818–1826
https://doi.org/10.2337/dc16-0721
Published: 26 July 2016
View articletitled, Intensive Glycemic Therapy in Patients With Type 2 Diabetes on β-Blockers
Open the PDF for Intensive Glycemic Therapy in Patients With Type 2 Diabetes on β-Blockers in another window
Includes: Supplementary data
Journal Articles

Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients

Open Access
Tetsuro Tsujimoto, Ritsuko Yamamoto-Honda, Hiroshi Kajio, Miyako Kishimoto, Hiroshi Noto, Remi Hachiya, Akio Kimura, Masafumi Kakei, Mitsuhiko Noda
Journal: Diabetes Care
Diabetes Care 2014;37(1):217–225
https://doi.org/10.2337/dc13-0701
Published: 11 December 2013
View articletitled, Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients
Open the PDF for Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients in another window
Includes: Supplementary data
Journal Articles

Effect of Longitudinal Changes in Visceral Fat Area and Other Anthropometric Indices to the Changes in Metabolic Risk Factors in Japanese Men: The Hitachi Health Study

Open Access
Yumi Matsushita, PHD, Toru Nakagawa, MD, Shuichiro Yamamoto, MD, Yoshihiko Takahashi, MD, Tetsuji Yokoyama, MD, Tetsuya Mizoue, MD, Mitsuhiko Noda, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):1139–1143
https://doi.org/10.2337/dc11-1320
Published: 11 April 2012
View articletitled, Effect of Longitudinal Changes in Visceral Fat Area and Other Anthropometric Indices to the Changes in Metabolic Risk Factors in Japanese Men: The Hitachi Health Study
Open the PDF for Effect of Longitudinal Changes in Visceral Fat Area and Other Anthropometric Indices to the Changes in Metabolic Risk Factors in Japanese Men: The Hitachi Health Study in another window
Journal Articles

Associations of Visceral and Subcutaneous Fat Areas With the Prevalence of Metabolic Risk Factor Clustering in 6,292 Japanese Individuals: The Hitachi Health Study

Open Access
Yumi Matsushita, PHD, Toru Nakagawa, MD, PHD, Shuichiro Yamamoto, MD, Yoshihiko Takahashi, MD, PHD, Tetsuji Yokoyama, MD, PHD, Mitsuhiko Noda, MD, PHD, Tetsuya Mizoue, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(9):2117–2119
https://doi.org/10.2337/dc10-0120
Published: 11 May 2010
View articletitled, Associations of Visceral and Subcutaneous Fat Areas With the Prevalence of Metabolic Risk Factor Clustering in 6,292 Japanese Individuals: The Hitachi Health Study
Open the PDF for Associations of Visceral and Subcutaneous Fat Areas With the Prevalence of Metabolic Risk Factor Clustering in 6,292 Japanese Individuals: The Hitachi Health Study in another window
Journal Articles

Insulin Allergy and Immunologic Insulin Resistance Caused by Interleukin-6 in a Patient With Lung Cancer

Free
Satomi Mizuhashi, MD, Keigo Nakamura, MD, PHD, Yasumichi Mori, MD, PHD, Mitsuhiko Noda, MD, Koji Nakanishi, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1711–1712
https://doi.org/10.2337/dc06-0677
Published: 01 July 2006
View articletitled, Insulin Allergy and Immunologic Insulin Resistance Caused by Interleukin-6 in a Patient With Lung Cancer
Open the PDF for Insulin Allergy and Immunologic Insulin Resistance Caused by Interleukin-6 in a Patient With Lung Cancer in another window